mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |